What is the Historic and Current Scenario of the Radiofrequency Ablation Devices Market?
The radiofrequency ablation devices market has seen considerable growth due to a variety of factors.
•In the last few years, there has been a rapid expansion in the market size of radiofrequency ablation devices. The market is projected to rise from $4.72 billion in 2024 to approximately $5.29 billion in 2025, displaying a compound annual growth rate (CAGR) of 12.2%.
Factors such as clinical acceptability, an increase in chronic diseases, patient demand, regulatory approvals as well as training and education contributed to the growth during the historical period.
What are the Forecasted Growth and Key Factors of the Radiofrequency Ablation Devices Market?
The radiofrequency ablation devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for radiofrequency ablation devices is anticipated to witness a swift expansion in the coming years, reaching a valuation of $8.54 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.7%.
The increase during the forecast period is due to factors such as the rising elderly population, advancements in regenerative medicine, adoption of value-based healthcare, incorporation of telemedicine, and the transition towards less invasive procedures. Key trends to watch for during this period encompass mobile ablation devices, combined therapies, techniques for cancer ablation, improved safety functions, and the application of remote and robotic assistance.
What Are the Critical Driver Fuelling the Radiofrequency Ablation Devices Market's Growth?
The rise in chronic illnesses is propelling the expansion of the radiofrequency ablation devices market. Chronic conditions are those that persist for a year or more, require ongoing medical attention, limit daily activities, or both. People suffering from chronic and arthritic joint pain frequently use radiofrequency ablation devices for relief. Additionally, these devices are commonly employed to reduce the size of tumors, nodules, or other bodily growths. For example, the National Library of Medicine, a reputable US-based biomedical library, predicted in January 2023 that the number of people aged 50 and older with at least one chronic disease would skyrocket by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Consequently, the uptick in chronic illnesses is fueling the expansion of the radiofrequency ablation devices market.
How Is the Radiofrequency Ablation Devices Market segmented?
The radiofrequency ablation devices market covered in this report is segmented –
1) By Product Type: Disposables Equipment, Reusables Equipment, Capital Equipment
2) By Application: Oncology, Cardiology And Cardiac Rhythm Management, Gynecology, Pain Management, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Disposables Equipment: Ablation Catheters, Electrode Pads, Temperature Probes, Insulated Wires
2) By Reusables Equipment: RF Generators, Handpieces, Lead Wires
3) By Capital Equipment: RF Ablation Systems, Integrated Imaging Systems, Surgical Tables With RF Ablation Features
Pre-Book The Radiofrequency Ablation Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Radiofrequency Ablation Devices Market?
The progress in technology is becoming a prominent trend in the radiofrequency ablation devices market. Main players in this market are concentrating on creating cutting-edge technical solutions to maintain their market standing. For example, Compal Electronics, an electronic firm based in Taiwan, launched its new radiofrequency ablation system, AblatePal, in April 2023. The system, designed for percutaneous and intraoperative coagulation and ablation of soft tissue, uses the heat energy generated by electrical resistance during current flow in the tissue to burn the tumour, causing tumour necrosis. Its cutting-edge cooling technology avoids harm to healthy tissue and has demonstrated promising results that can lessen wound size and reduce patients' hospital stay.
Who Are the Key Players in the Radiofrequency Ablation Devices Market?
Major companies operating in the radiofrequency ablation devices market include:
• Johnson And Johnson Co
• Abbott Laboratories
• Medtronic PLC
• Becton
• Dickinson and Company
• Koninklijke Philips NV
• Stryker Corporation
• Boston Scientific Corporation
• Olympus Corporation
• Smith And Nephew PLC
• Ethicon Inc.
• Hologic Inc.
• Arthrex Inc.
• BIOTRONIK SE and Co KG
• Merit Medical Systems Inc.
• Conmed Corporation
• Avanos Medical Inc.
• ArtiCure Inc.
• AngioDynamics Inc.
• Biosense Webster Inc.
• Baylis Medical Company Inc.
• Sutter Medizintechnik GmbH
• OSYPKA AG
• Inomed Medizintechnik GmbH
• St. Jude Medical Inc.
• Epimed International Inc.
What Is The Most Dominant Region In The Radiofrequency Ablation Devices Market?
North America was the largest region in the radiofrequency ablation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiofrequency ablation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
